Sugi Predict

Sugi Predict / Compounds / SCHEMBL29636367

SCHEMBL29636367

SCHEMBL29636367

CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 11/20 0.48
▸ NPY1R P25929 6/20 0.48
▸ NPY2R P49146 4/20 0.48
▸ NPY5R Q15761 4/20 0.48
▸ FURIN P09958 5/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ SIRT5 Q9NXA8 1/20 0.38
▸ CTSD P07339 1/20 0.38
▸ BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3074247 0.98 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL29636356 0.98 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL3074240 0.98 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL29636369 0.96 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL29603879 0.96 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL29636351 0.94 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL1527410 0.93 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL30945410 0.93 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL1527412 0.93 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN
SCHEMBL30945400 0.93 NPY4R (0.51) NPY4RNPY1RNPY2RNPY5RFURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3187508-B1 LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF BIOMARIN PHARM INC (US) 2026-04-22 — — EP disclosed
US-20230241187-A1 Lysosomal Targeting Peptides and Uses Thereof BIOMARIN PHARMACEUTICAL INC. 2023-08-03 — — US disclosed
US-20220354934-A1 Lysosomal Targeting Peptides and Uses Thereof BIOMARIN PHARMACEUTICAL INC. 2022-11-10 — — US disclosed
US-11351231-B2 Lysosomal targeting peptides and uses thereof BIOMARIN PHARMACEUTICAL INC. (US) 2022-06-07 — — US disclosed